Mount Sinai's Pediatric AIDS Clinical Trials Unit (ACTU) is applying for competitive renewal of its multi-hospital consortium to conduct clinical trials of new treatments for pediatric and perinatal HIV infection and the associated opportunistic infections and malignancies. Mount Sinai is been involved in the ACTG program since 1987 and has developed the capability to generate protocols, to recruit patients with HIV infection, coordinate data and specimen collection, perform virologic and immunologic evaluations, as well as pharmacokinetic studies, maintain quality control of laboratory results and data entry, and to collaborate with NIAID and the other institutions involved in adult and pediatric trials. The Adult and Pediatric units are integrated with each other and with clinical care. At each site the adult and pediatric units share space, administration and data management. The pediatric and Adult ACTUs serve as referral sources for each other and collaborate to provide a family-oriented program which increases accrual and retention. The immunology and virology laboratories process adult and pediatric specimens. Together the units have enrolled over 800 patients on more than 40 different protocols, and have consistently been among the leaders in enrollment of women, minorities, and intravenous drug users. The studies will be conducted at three hospitals (Mount Sinai Hospital, Beth Israel Medical Center and Elmhurst Hospital Center) which serve some of the highest AIDS incidence areas in the country and can offer access to trials to large numbers of HIV- infected women and children from groups which have been underrepresented in trials. The Pediatric ACTU will continue to participate in studies of perinatal transmission (where its investigators have been among the leaders), antiretroviral therapy and therapy of opportunistic infections. The unit plans to accrue and retain 30 to 35 new subjects per year.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI027554-07
Application #
2063915
Study Section
Special Emphasis Panel (SRC (51))
Project Start
1988-09-30
Project End
1997-08-31
Budget Start
1994-09-01
Budget End
1995-08-31
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Miscellaneous
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Mirochnick, M; Capparelli, E; Dankner, W et al. (1998) Zidovudine pharmacokinetics in premature infants exposed to human immunodeficiency virus. Antimicrob Agents Chemother 42:808-12
Weinberg, R S; Chusid, E D; Galperin, Y et al. (1998) Effect of antiviral drugs and hematopoietic growth factors on in vitro erythropoiesis. Mt Sinai J Med 65:5-13
Marcus, A M; Rose, D N; Sacks, H S et al. (1997) BCG vaccination to prevent tuberculosis in health care workers: a decision analysis. Prev Med 26:201-7
Villari, P; Spino, C; Chalmers, T C et al. (1993) Cesarean section to reduce perinatal transmission of human immunodeficiency virus. A metaanalysis. Online J Curr Clin Trials Doc No 74:[5107 words;46 paragraphs]
Rose, D N; Schechter, C B; Sacks, H S (1993) Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am J Med 94:160-8
Rose, D N; Schechter, C B; Sacks, H S (1992) Preventive medicine for HIV-infected patients: an analysis of isoniazid prophylaxis for tuberculin reactors and for anergic patients. J Gen Intern Med 7:589-94
Diamant, E P; Dische, R M; Barzilai, A et al. (1992) Chronic epiglottitis in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 11:770-1
Kugler, S L; Barzilai, A; Hodes, D S et al. (1991) Acute hemiplegia associated with HIV infection. Pediatr Neurol 7:207-10
Barzilai, A; Sperling, R S; Hyatt, A C et al. (1990) Mother to child transmission of human immunodeficiency virus 1 infection despite zidovudine therapy from 18 weeks of gestation. Pediatr Infect Dis J 9:931-3